Probiodrug Funds Brigham and Women’s Research into Antibody Targeting Pyroglutamated Abeta for Treatment of Alzheimer’s Disease

Probiodrug Publishes Further Evidence Correlating Glutaminyl Cyclase (QC) with Alzheimer’s Disease Pathogenesis and Cognitive Decline
Probiodrug Transfers its CDK9 Inhibitor Program to AstraZeneca